Bristol Myers Squibb Co (BMY) Debt Ratio (2009 - 2026)
Bristol Myers Squibb (BMY) posted quarterly Debt Ratio of 0.5 for Q2 2026, down 11.64% year-over-year from 0.57 in Q2 2025, and down 6.76% quarter-over-quarter from 0.54 in Q1 2026.
Bristol Myers Squibb Co (BMY) Debt Ratio (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has reported Debt Ratio for 18 consecutive years, with 0.5 the latest figure, recorded in Q2 2026.
- In Q2 2026, Debt Ratio fell 11.64% year-over-year to 0.5; the TTM figure through Jun 2026 stood at 0.5 (down 11.64% YoY), while the FY2025 annual figure was 0.52, down 5.92% from the prior year.
- Debt Ratio eased to 0.5 in Q2 2026 per BMY's latest filing, from 0.54 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.59 in Q1 2024 and bottomed at 0.42 in Q3 2022.
- Historically, Debt Ratio has averaged 0.51 across 5 years, with a median of 0.52 in 2022.
- Annual changes were most pronounced in 2023 — Debt Ratio fell 16.19% — and 2024, when it jumped 39.06%.
- Bristol Myers Squibb's Debt Ratio stood at 0.45 in 2022, then grew by 0.4% to 0.45 in 2023, then grew by 24.04% to 0.56 in 2024, then retreated by 5.92% to 0.52 in 2025, then slipped by 4.24% to 0.5 in 2026.
- Business Quant data shows BMY's Debt Ratio at 0.5 in Q2 2026, 0.54 in Q1 2026, and 0.52 in Q4 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.50 |
| Mar 31, 2026 | 0.54 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.57 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.56 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.56 |
| Dec 31, 2023 | 0.45 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.41 |
| Sep 30, 2021 | 0.45 |